Lake Street Maintains OptiNose(OPTN.US) With Buy Rating
Lake Street Sticks to Their Buy Rating for Optinose (OPTN)
Optinose's XHANCE Poised for Market Expansion and Growth: A Buy Rating Review
OptiNose Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: ScPharmaceuticals (SCPH), Optinose (OPTN)
Optinose's XHANCE Expansion Drives Buy Rating Amidst Growth Potential
Lake Street Reaffirms Their Buy Rating on Optinose (OPTN)
Analysts' Top Healthcare Picks: Longeveron (LGVN), Optinose (OPTN)
OptiNose Analyst Ratings
Lake Street Remains a Buy on Optinose (OPTN)
Lake Street Sticks to Their Buy Rating for Optinose (OPTN)
Analysts' Top Healthcare Picks: Soleno Therapeutics (SLNO), Optinose (OPTN)
OptiNose Analyst Ratings
OptiNose Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Joint (JYNT), IGM Biosciences (IGMS) and Optinose (OPTN)
Piper Sandler Reaffirms Their Buy Rating on Optinose (OPTN)
Analysts Are Bullish on Top Healthcare Stocks: Haemonetics (HAE), Optinose (OPTN)
Lake Street Initiates Coverage On OptiNose With Buy Rating, Announces Price Target of $3
OptiNose Analyst Ratings
OptiNose Analyst Ratings
No Data
No Data